BlossomHill Therapeutics, Inc. (BLSM) stock
Close on Nov 13, 2026Market cap $35.73MP/E –Yield –
BlossomHill Therapeutics statistics
28 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
Share statisticsIndustry
Short sellingIndustry
- Short Interest
- 590,133
- –
- Short Interest Change
- 21.7%
- -0.80%
- Short % of Shares Outstanding
- 23.2%
- 6.30%
- Days to Cover
- 4.65
- 5.15
Stock price statisticsIndustry
- 20-Day Moving Average
- $14.45
- –
- 50-Day Moving Average
- $18.01
- –
- Average True Range (14)
- $1.78
- –
- Price Change (1 Week)
- 3.85%
- -1.15%
- Price Change (1 Month)
- -6.41%
- -4.87%
- Price Change (3 Months)
- -14.4%
- -21.0%
- Average Volume (10 Days)
- 219,421
- –
- Average Volume (20 Days)
- 166,227
- –
- Average Volume (90 Days)
- 225,724
- –
- Relative Volume
- 0.99
- 0.70
- Relative Strength Index (14)
- 44.7
- 43.4
Financial positionIndustry
- Current Ratio
- 5.42
- 3.30
- Quick Ratio
- 5.12
- 2.39
Balance sheetIndustry
- Net Cash (Debt)
- $95.38M
- $17.76M
- Net Cash Per Share
- $37.42
- $0.80
- Equity (Book Value)
- -$174.78M
- $53.89M
- Book Value Per Share
- -$68.58
- $1.50
- Tangible Book Value
- -$174.78M
- $27.13M
- Working Capital
- $82.35M
- $79.99M
Scores and fair valueIndustry
- Altman Z-Score
- -0.72
- 0.23
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | BLSM | S&P 500 | Difference | BLSM per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -9.4% | -3.0% | −6.4 pts | ||
| 3 months | -14.3% | -2.8% | −11.5 pts | ||
| Year to date | +804.5% | +11.5% | +793.0 pts | ||
| 1 year | +804.5% | +13.5% | +791.1 pts | ||
| 3 years | +804.5% | +77.7% | +726.8 pts | +108.4% | +21.1% |
| 5 years | +804.5% | +72.6% | +731.9 pts | +55.3% | +11.5% |
| 10 years | +804.5% | +308.2% | +496.4 pts | +24.6% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
1M BLSM shares were sold short on Oct 30, 2026, up 21.7% from the previous report. At recent volumes it would take 4.7 days to buy them back. Over the last 20 sessions, 64.7% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 590,133 | +21.7% | 126,894 | 4.7 |
| Oct 15, 2026 | 484,963 | +2.4% | 168,683 | 2.9 |
| Sep 30, 2026 | 473,807 | +244.4% | 291,746 | 1.6 |
| Sep 15, 2026 | 137,567 | +24.2% | 157,039 | 1.0 |
| Aug 31, 2026 | 110,782 | -1.0% | 160,200 | 1.0 |
| Aug 14, 2026 | 111,892 | – | 360,667 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?